Safe adoptive transfer of virus‐specific T‐cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation
暂无分享,去创建一个
T. Lion | R. Handgretinger | G. Jahn | C. Peters | R. Lotfi | M. Fuhrer | R. Beck | P. Lang | S. Matthes-Martin | M. Schumm | T. Feuchtinger | F. Schuster | K. Hamprecht | C. Richard | S. Matthes‐Martin
[1] H. Stauss,et al. Antigen-specific cellular immunotherapy of leukemia , 2005, Leukemia.
[2] P. Veys,et al. Improved outcome for children with disseminated adenoviral infection following allogeneic stem cell transplantation , 2005, British journal of haematology.
[3] S. Rosenberg,et al. Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells. , 2005, The Journal of clinical investigation.
[4] V. Saha,et al. Adenovirus infection after pediatric bone marrow transplantation: is treatment always necessary? , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[5] M. Schilham,et al. Immune reconstitution and clearance of human adenovirus viremia in pediatric stem-cell recipients. , 2005, The Journal of infectious diseases.
[6] R. Handgretinger,et al. Detection of adenovirus‐specific T cells in children with adenovirus infection after allogeneic stem cell transplantation , 2005, British journal of haematology.
[7] C. Rooney,et al. Adenovirus as an emerging pathogen in immunocompromised patients , 2005, British journal of haematology.
[8] C. Rooney,et al. Conserved CTL epitopes on the adenovirus hexon protein expand subgroup cross-reactive and subgroup-specific CD8+ T cells. , 2004, Blood.
[9] M. Bevan,et al. CD4+ T cells are required for the maintenance, not programming, of memory CD8+ T cells after acute infection , 2004, Nature Immunology.
[10] M. Schilham,et al. Effect of ribavirin on the plasma viral DNA load in patients with disseminating adenovirus infection. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[11] H. Einsele,et al. Isolation and expansion of human adenovirus-specific CD4+ and CD8+ T cells according to IFN-gamma secretion for adjuvant immunotherapy. , 2004, Experimental hematology.
[12] D. Olive,et al. Infectious complications following allogeneic HLA-identical sibling transplantation with antithymocyte globulin-based reduced intensity preparative regimen , 2003, Leukemia.
[13] D. Douek,et al. Early reconstitution of the T‐cell repertoire after non‐myeloablative peripheral blood stem cell transplantation is from post‐thymic T‐cell expansion and is unaffected by graft‐versus‐host disease or mixed chimaerism , 2003, British journal of haematology.
[14] F. Watzinger,et al. Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease. , 2003, Blood.
[15] A. Heim,et al. Rapid and quantitative detection of human adenovirus DNA by real‐time PCR , 2003, Journal of medical virology.
[16] M. Schilham,et al. Extensive Cross-Reactivity of CD4+ Adenovirus-Specific T Cells: Implications for Immunotherapy and Gene Therapy , 2003, Journal of Virology.
[17] M. Horwitz,et al. The impact of adenovirus infection on the immunocompromised host , 2003, Reviews in medical virology.
[18] H. Einsele,et al. Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation , 2003, Bone Marrow Transplantation.
[19] T. Klingebiel,et al. Transplantation of highly purified CD34+ progenitor cells from unrelated donors in pediatric leukemia. , 2003, Blood.
[20] T. Walls,et al. Adenovirus: an increasingly important pathogen in paediatric bone marrow transplant patients. , 2003, The Lancet. Infectious diseases.
[21] D. Ho,et al. Direct evidence for new T-cell generation by patients after either T-cell–depleted or unmodified allogeneic hematopoietic stem cell transplantationsPresented in part in abstract form at the 42nd Annual Meeting of the American Society of Hematology, San Francisco, CA, December 2000. , 2002 .
[22] D. Ho,et al. Direct evidence for new T-cell generation by patients after either T-cell-depleted or unmodified allogeneic hematopoietic stem cell transplantations. , 2002, Blood.
[23] C. Fegan,et al. Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery. , 2002, Blood.
[24] L. Eisenlohr,et al. The adenovirus capsid protein hexon contains a highly conserved human CD4+ T-cell epitope. , 2002, Human gene therapy.
[25] P. Gavin,et al. Intravenous ribavirin treatment for severe adenovirus disease in immunocompromised children. , 2002, Pediatrics.
[26] Hans-Georg Rammensee,et al. Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy. , 2002, Blood.
[27] T. Klingebiel,et al. Immunological Aspects of Haploidentical Stem Cell Transplantation in Children , 2001, Annals of the New York Academy of Sciences.
[28] J. Towbin,et al. Association of viral genome with graft loss in children after cardiac transplantation. , 2001, The New England journal of medicine.
[29] A. L. Le Faou,et al. Treatment of adenovirus infections in patients undergoing allogeneic hematopoietic stem cell transplantation. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[30] L. Elting,et al. Adenovirus infections in adult recipients of blood and marrow transplants. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[31] M. Peuchmaur,et al. Early diagnosis of adenovirus infection and treatment with cidofovir after bone marrow transplantation in children , 2001, Bone Marrow Transplantation.
[32] D. Pillay,et al. Adenovirus infections following haematopoietic cell transplantation: is there a role for adoptive immunotherapy? , 2000, Bone Marrow Transplantation.
[33] M Pittard,et al. Adenovirus infections in hematopoietic stem cell transplant recipients. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[34] D. Srivastava,et al. Infusion of Cytotoxic T Cells for the Prevention and Treatment of Epstein-Barr Virus–Induced Lymphoma in Allogeneic Transplant Recipients , 1998 .
[35] S. Riddell,et al. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. , 1995, The New England journal of medicine.
[36] R. Truitt,et al. Characterization of human proliferative T cell responses to adenovirus. , 1995, The Journal of infectious diseases.
[37] K. Cornetta,et al. Donor leukocyte infusion as therapy of life-threatening adenoviral infections after T-cell-depleted bone marrow transplantation. , 1994, Blood.
[38] M. Horowitz,et al. Increasing incidence of adenovirus disease in bone marrow transplant recipients. , 1994, The Journal of infectious diseases.
[39] S. Riddell,et al. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. , 1992, Science.
[40] P. Moss,et al. Cellular immunotherapy for viral infection after HSC transplantation , 2005, Nature Reviews Immunology.
[41] C. Rouzioux,et al. Real-time blood plasma polymerase chain reaction for management of disseminated adenovirus infection. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[42] Mario Roederer,et al. Dear Reader, , 2003, Nature Medicine.
[43] D. Srivastava,et al. Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients. , 1998, Blood.